DoD invests in medical swab production
The US Department of Defense (DoD) has awarded Puritan Medical Products a $75.5 million investment as part of the Defence Production Act Title 3 funding.
This investment will increase swab production by 20 million units per month from May 2020 onwards and will fund a new manufacturing facility in Pittsfield, Maine. As a result, the company will be capable of expanding output to 40 million medical swabs each month.
In addition, the company will expand its workforce by employing an extra 150 people to work at the new Pittsfield site, according to Lt Col Mike Andrews, a spokesperson at the DoD.
More from Defence Notes
-
Pentagon’s FY26 defence budget proposal is $130 billion more than US Congress plans to provide
The House Committee on Appropriations approved a FY2026 bill reducing investments in main defence programmes.
-
What role could holographic and 3D capabilities play in the warfare of tomorrow
Holographic and 3D technologies have been lauded by some for their ability to provide technical and operational advantages for military training and planning. But is the hype truly justified?
-
Unfolding the Golden Dome for America: Seven things you should know about the programme
Shephard talked to multiple experts about the most pressing concerns and considerations regarding the air defence system advocated by President Trump.
-
Industry welcomes UK Strategic Defence Review, but pressure remains on future defence investment plans
While industry reception to the SDR has been positive, questions still remain from analyst and trade associations about what this could mean for future investment and the future UK Defence Industrial Strategy.
-
UK Strategic Defence Review puts emphasis on autonomy, airpower and munitions
The UK’s Strategic Defence Review (SDR) was launched as one of the first acts of the UK’s new Labour Government in June last year. The review has recommended a major big-picture reform of the country’s forces.